Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

It's not often a famous composer helps solve a 200-year-old mystery, but DNA from Beethoven's hair might actually do that.

Currently, there is no feline vaccine for the hepatitis B virus, and the hepatitis B vaccine for humans is highly toxic to ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

2 German Center for Infection Research, Hamburg-Lübeck-Borstel-Riems, Munich and Heidelberg sites, Germany Objectives A major goal of curative hepatitis B virus (HBV) treatments is the reduction or ...

ki.se Objective Chronic HBV/HDV infections are a major cause of liver cancer ... Naïve serum was included as control and all conditions were performed in duplicate. This virus-antiserum mixture was ...

Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...

Chronic HBV infection is the most ... by acting on multiple steps that the virus uses to replicate and integrate its DNA into an infected individual’s genome. By blocking these key processes ...

The majority of children and adults who receive the hepatitis B (hep B) virus vaccine do not need a booster. The six hepatitis B vaccines licensed for use in the United States afford lifelong ...

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer than six months are considered "chronic." Chronic hepatitis B (CHB ...